Standards; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Tesofensine, is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is currently in clinical development for the treatment of obesity.